C50.011
Malignant neoplasm of nipple and areola, right female breast
Clinical Classification Guidelines
Medical Intelligence & Overview
C50.011 refers to a malignant tumor located in the nipple and areola region of the right female breast. This type of breast cancer originates from the cells lining the ducts or lobules that produce milk. As a malignant neoplasm, it has the potential to invade surrounding tissues and spread to other parts of the body if not diagnosed and treated early. Recognizing the characteristics and associated factors of this specific cancer can guide women and healthcare providers in taking appropriate steps for diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations that influence cell growth Family history of breast cancer Hormonal factors, such as prolonged exposure to estrogen Previous history of breast cancer or other cancers Environmental exposures, including radiation Lifestyle factors like alcohol consumption and obesity Age, with risk increasing as women grow older
Key Symptoms: A visible lump or thickening in the nipple or areola area Discharge from the nipple, which may be bloody or clear Changes in the skin of the nipple or areola, such as redness, scaling, or ulceration Nipple inversion or flattening Persistent pain in the affected area Alterations in the size or shape of the breast Swelling or enlarged lymph nodes nearby
Diagnostic & Treatment
Diagnosis Path: Clinical breast examination to assess physical changes Imaging tests such as mammography and ultrasound to detect abnormalities Biopsy procedures, including fine needle aspiration or core needle biopsy, to obtain tissue samples for histopathological analysis Magnetic resonance imaging (MRI) may be utilized to evaluate the extent of the disease Lymph node assessment through imaging or biopsy to determine spread
Treatment Protocols: Surgical procedures such as excision of the tumor (lumpectomy) or mastectomy, depending on the extent of disease Radiation therapy to destroy residual cancer cells post-surgery Chemotherapy to target cancer cells systemically, especially in cases with higher risk of spread Hormonal therapy if the tumor is hormone receptor-positive Targeted therapy aimed at specific molecular markers present in the tumor Follow-up care to monitor for recurrence and manage any side effects of treatment
Clinical Advice & FAQs
Billing Guidance
Is C50.011 a billable ICD-10 code?
Yes, C50.011 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C50.011?
Clinical documentation must specify the nature of Malignant neoplasm of nipple and areola, right female breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference